Page last updated: 2024-09-04

canertinib and Cancer of Colon

canertinib has been researched along with Cancer of Colon in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brattain, MG; Foster, JM; Koterba, AP; Kreisberg, JI; Rajput, A; Willson, JK1

Other Studies

1 other study(ies) available for canertinib and Cancer of Colon

ArticleYear
A novel mechanism of resistance to epidermal growth factor receptor antagonism in vivo.
    Cancer research, 2007, Jan-15, Volume: 67, Issue:2

    Topics: Animals; Apoptosis; Cell Growth Processes; Cell Line, Tumor; Colonic Neoplasms; Drug Resistance, Neoplasm; Enzyme Activation; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Humans; Immunohistochemistry; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Morpholines; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptor, ErbB-2; Signal Transduction; Transfection; Transforming Growth Factor alpha; Xenograft Model Antitumor Assays

2007